Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
OPERATING ACTIVITIES    
Net loss $ (28,407,209) $ (39,087)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation and amortization 1,484,148 0
Impairment of goodwill 26,998,125 0
Amortization of debt discount 67,095 0
Change in operating assets and liabilities:    
Prepaid expense 0 1,750
Prepaid inventory 66,164 0
Inventory (2,048,942) 0
Accounts receivable (1,265,295) 0
Accounts payable and accrued expenses 211,514 6,732
Net cash flows used in operating activities (2,894,400) (30,605)
INVESTING ACTIVITIES    
Cash received on acquisition 50,775 0
Purchase of equipment (201,199) 0
Cash paid on PhytoSPHERE agreement (950,000) 0
Investment in KanaLife Sciences (650,000) 0
Net cash flows from investing activities (1,750,424) 0
FINANCING ACTIVITIES    
Proceeds from related party loans 0 29,600
Proceeds from loan from Roen Ventures 4,780,500 0
Proceeds from equipment loan, net of repayment 30,000 0
Repayment of loan from related party (200) 0
Net cash flows from financing activities 4,810,300 29,600
Net increase (decrease) in cash 165,476 (1,005)
Cash, beginning of period 431 1,168
Cash, end of period 165,907 163
NON CASH TRANSACTION:    
Accounts receivable assumed from acquisitions 396,438 0
Inventory assumed from acquisitions 345,477 0
Prepaid inventory assumed from acquisition 1,260,510 0
Property and equipment assumed from acquisitions 1,288 0
Intangible assets 5,947,387 0
Goodwill 26,998,125 0
Amount due from PhytoSPHERE agreement (6,499,998) 0
Common Shares to be issued for PhytoSPHERE Transaction $ (27,550,002) $ 0